跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TIROCAP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TIROCAP
Authorized
STANDARD
TIROCAP
IBSA Institut Biochimique SA
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
9ba2b3931db76aa1
Company
IBSA Institut Biochimique SA
Type
Standard
Approval Details
Approval Id
9ba2b3931db76aa1
Drug Approval Canada Name
TIROCAP
Product Name
TIROCAP
Status
Cancelled Pre Market
Status Date
2024-03-28
Din
02508567
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
68:36.04
Atc Original
H03AA01 LEVOTHYROXINE SODIUM
Atc Name
h 03 aa 01
Aig Number
0107794013
Company Name
IBSA Institut Biochimique SA
Company Address
Via Pian Scairolo 49, Pazzallo, --, Switzerland, 6912
Company Detail Path
/organization/ibsa-institut-biochimique-sa
Company Information
Pharmaceutical Company Name
IBSA Institut Biochimique SA
Name Zh
IBSA生化研究所有限公司
Country Name
Netherlands
Province Name
Gelderland
City Name
arnhem,gelderland,country_nl
Address
Velperplein 23
Website
http://www.ibsagroup.com
Active Ingredients
LEVOTHYROXINE SODIUM
137 MCG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
9ba2b3931db76aa1
Type
Standard
Back to Health Canada Approvals